文献速递糖尿病

通过公共卫生筛查诊断为症状前1型糖尿病的儿童在临床发病时糖尿病病情较轻

Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation.
PubMed 文献 · Diabetologia · 2023-06-17

研究比较Fr1da筛查项目中128名症状前1型糖尿病儿童与DiMelli研究中736名未筛查儿童在临床发病时的表现。筛查组诊断时HbA1c、空腹血糖、酮尿症和胰岛素需求均更低,糖尿病酮症酸中毒仅2.5%。结论认为症状前诊断联合教育与监测可改善临床发病表现。

要点

  • 筛查组诊断时中位HbA1c为51 mmol/mol(6.8%),未筛查组为91 mmol/mol(10.5%),p<0.001。
  • 筛查组酮尿症22.2%、需胰岛素治疗72.3%,未筛查组分别为78.4%和98.1%。
  • 筛查组仅2.5%以糖尿病酮症酸中毒起病,且参与教育与监测者临床表现更轻。

核心结论

  • 在儿童中诊断症状前1型糖尿病并随后进行教育与监测,可改善3期1型糖尿病发病时的临床表现。

研究设计与样本

  • Fr1da研究为基于人群的胰岛自身抗体筛查项目,纳入2015至2022年间128名既往诊断为症状前早期1型糖尿病的儿童。
  • DiMelli研究为对照来源,纳入2009至2018年间736名既往未筛查、年龄相近的初发1型糖尿病儿童。
  • 比较两组在3期1型糖尿病诊断时获得的临床数据。

主要发现

  • 3期诊断时,既往早期诊断组中位HbA1c为51 mmol/mol(6.8%),无既往早期诊断组为91 mmol/mol(10.5%),p<0.001。
  • 既往早期诊断组中位空腹血糖为5.3 mmol/l,无既往早期诊断组为7.2 mmol/l,p<0.05。
  • 既往早期诊断组中位空腹C肽为0.21 nmol/l,无既往早期诊断组为0.10 nmol/l,p<0.001。
  • 既往早期诊断组酮尿症比例为22.2%,无既往早期诊断组为78.4%,p<0.001。
  • 既往早期诊断组需胰岛素治疗比例为72.3%,无既往早期诊断组为98.1%,p<0.05;既往早期诊断组仅2.5%以糖尿病酮症酸中毒起病。

关键数值与推荐

  • 既往早期诊断儿童在3期诊断时的结局与1型糖尿病家族史或COVID-19大流行期间诊断无关。
  • 在早期诊断后参与教育与监测的儿童中观察到更轻的临床表现。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We aimed to determine whether disease severity was reduced at onset of clinical (stage 3) type 1 diabetes in children previously diagnosed with presymptomatic type 1 diabetes in a population-based screening programme for islet autoantibodies. METHODS: Clinical data obtained at diagnosis of stage 3 type 1 diabetes were evaluated in 128 children previously diagnosed with presymptomatic early-stage type 1 diabetes between 2015 and 2022 in the Fr1da study and compared with data from 736 children diagnosed with incident type 1 diabetes between 2009 and 2018 at a similar age in the DiMelli study without prior screening. RESULTS: At the diagnosis of stage 3 type 1 diabetes, children with a prior early-stage diagnosis had lower median HbA1c (51 mmol/mol vs 91 mmol/mol [6.8% vs 10.5%], p<0.001), lower median fasting glucose (5.3 mmol/l vs 7.2 mmol/l, p<0.05) and higher median fasting C-peptide (0.21 nmol/l vs 0.10 nmol/l, p<0.001) compared with children without previous early-stage diagnosis. Fewer participants with prior early-stage diagnosis had ketonuria (22.2% vs 78.4%, p<0.001) or required insulin treatment (72.3% vs 98.1%, p<0.05) and only 2.5% presented with diabetic ketoacidosis at diagnosis of stage 3 type 1 diabetes. Outcomes in children with a prior early-stage diagnosis were not associated with a family history of type 1 diabetes or diagnosis during the COVID-19 pandemic. A milder clinical presentation was observed in children who participated in education and monitoring after early-stage diagnosis. CONCLUSIONS/INTERPRETATION: Diagnosis of presymptomatic type 1 diabetes in children followed by education and monitoring improved clinical presentation at the onset of stage 3 type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hummel S, Carl J, Friedl N, et al. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia. 2023. PMID: 37329450. doi:10.1007/s00125-023-05953-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。